ARS Pharmaceuticals Inc (NASDAQ: SPRY) kicked off on Monday, up 8.29% from the previous trading day, before settling in for the closing price of $10.49. Over the past 52 weeks, SPRY has traded in a range of $6.66-$18.90.
While this was happening, its average annual earnings per share was recorded -2241.67%. With a float of $59.73 million, this company’s outstanding shares have now reached $98.84 million.
ARS Pharmaceuticals Inc (SPRY) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of ARS Pharmaceuticals Inc is 39.57%, while institutional ownership is 63.79%. The most recent insider transaction that took place on Nov 13 ’25, was worth 190,050. In this transaction Chief Operating Officer of this company sold 21,828 shares at a rate of $8.71, taking the stock ownership to the 10,789 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Business Officer sold 166,380 for $8.87, making the entire transaction worth $1,476,147. This insider now owns 0 shares in total.
ARS Pharmaceuticals Inc (SPRY) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.51 earnings per share (EPS), higher than consensus estimate (set at -0.12) by 0.63. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2241.67% per share during the next fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
Take a look at ARS Pharmaceuticals Inc’s (SPRY) current performance indicators. Last quarter, stock had a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.29 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
Analysing the last 5-days average volume posted by the [ARS Pharmaceuticals Inc, SPRY], we can find that recorded value of 1.67 million was lower than the volume posted last year of 1.87 million. As of the previous 9 days, the stock’s Stochastic %D was 47.45%.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 41.45%, which indicates a significant decrease from 94.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.36, while its 200-day Moving Average is $12.81. Now, the first resistance to watch is $11.80. This is followed by the second major resistance level at $12.24. The third major resistance level sits at $12.97. If the price goes on to break the first support level at $10.62, it is likely to go to the next support level at $9.89. Should the price break the second support level, the third support level stands at $9.45.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
The company with the Market Capitalisation of 1.12 billion has total of 98,849K Shares Outstanding. Its annual sales at the moment are 89,150 K in contrast with the sum of 8,000 K annual income. Company’s last quarter sales were recorded 32,500 K and last quarter income was -51,150 K.
